PureTech publishes phase 2b trial results for lung fibrosis drug

April 2, 2026 8:19 AM

PureTech Health plc (NASDAQ: PRTC, LSE: PRTC) announced the publication of results from its Phase 2b ELEVATE IPF trial of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found